Phase Ib study of NGR-hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours von Gregorc, V, Santoro, A, Bennicelli, E, Punt, C J A, Citterio, G, Timmer-Bonte, J N H, Caligaris Cappio, F, Lambiase, A, Bordignon, C, van Herpen, C M L

Volltext

Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL von Brown, J R, Hillmen, P, O’Brien, S, Barrientos, J C, Reddy, N M, Coutre, S E, Tam, C S, Mulligan, S P, Jaeger, U, Barr, P M, Furman, R R, Kipps, T J, Cymbalista, F, Thornton, P, Caligaris-Cappio, F, Delgado, J, Montillo, M, DeVos, S, Moreno, C, Pagel, J M, Munir, T, Burger, J A, Chung, D, Lin, J, Gau, L, Chang, B, Cole, G, Hsu, E, James, D F, Byrd, J C

Volltext

ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL) von Ghielmini, M., Vitolo, U., Kimby, E., Montoto, S., Walewski, J., Pfreundschuh, M., Federico, M., Hoskin, P., McNamara, C., Caligaris-Cappio, F., Stilgenbauer, S., Marcus, R., Trneny, M., Dreger, P., Montserrat, E., Dreyling, M., Agostinelli, Claudio, Arcaini, Luca, Caligaris-Cappio, Federico, Campo, Elias, Coiffier, Bertrand, Corradini, Paolo, D'Amore, Francesco, Dreger, Peter, Dreyling, Martin, Federico, Massimo, Gallamini, Andrea, Gaulard, Philippe, Geisler, Christian H., Ghielmini, Michele, Gisselbrecht, Christian, da Silva, Maria Gomes, Gribben, John, Hermine, Olivier, Hoskin, Peter, Iannitto, Emilio, Kim, Won Seog, Kimby, Eva, Kluin-Nelemans, Hanneke C., Koch, Peter, Ladetto, Marco, Le Gouill, Steven, Lopez-Guillermo, Armando, Marcus, Robert, McNamara, Christopher, Montalban, Carlos, Montoto, Silvia, Montserrat, Emili, Pfreundschuh, Michael, Raderer, Markus, Rodriguez, José, Salles, Gilles, Bernard, Claude, Schmitz, Norbert, Shpilberg, Ofer, Stilgenbauer, Stephan, Thieblemont, Catherine, Tilly, Hervé, Tournilhac, Olivier, Trümper, Lorenz, Vitolo, Umberto, Walewski, Jan, Wotherspoon, Andrew, Zucca, Emanuele

Volltext

B cells and macrophages pursue a common path toward the development and progression of chronic lymphocytic leukemia von Galletti, G, Caligaris-Cappio, F, Bertilaccio, M T S

Volltext

International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia von RAWSTRON, A. C, VILLAMOR, N, EVAN, P. A. S, NATKUNAM, Y, COUTRE, S. E, AVERY, E. D, RASSENTI, L. Z, KIPPS, T. J, CALIGARIS-CAPPIO, F, KNEBA, M, BYRD, J. C, HALLEK, M. J, RITGEN, M, MONTSERRAT, E, HILLMEN, P, BÖTTCHER, S, GHIA, P, ZEHNDER, J. L, LOZANSKI, G, COLOMER, D, MORENO, C, GEUNA, M

Volltext

Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients von ARVANITI, Eleni, NTOUFA, Stavroula, MUZIO, Marta, BELESSI, Chrysoula, PAPAKONSTANTINOU, Nikos, TOULOUMENIDOU, Tasoula, LAOUTARIS, Nikolaos, ANAGNOSTOPOULOS, Achilles, LAMNISSOU, Klea, CALIGARIS-CAPPIO, Federico, STAMATOPOULOS, Kostas, GHIA, Paolo

Volltext

Xenograft models of chronic lymphocytic leukemia: problems, pitfalls and future directions von Bertilaccio, M T S, Scielzo, C, Simonetti, G, Ten Hacken, E, Apollonio, B, Ghia, P, Caligaris-Cappio, F

Volltext

Autoimmune disorders and lymphoma von Caligaris-Cappio, F.

Volltext

The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia von Scielzo, C, Apollonio, B, Scarfò, L, Janus, A, Muzio, M, ten Hacken, E, Ghia, P, Caligaris-Cappio, F

Volltext

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia von Byrd, John C, Brown, Jennifer R, O'Brien, Susan, Barrientos, Jacqueline C, Kay, Neil E, Reddy, Nishitha M, Coutre, Steven, Tam, Constantine S, Mulligan, Stephen P, Jaeger, Ulrich, Devereux, Steve, Barr, Paul M, Furman, Richard R, Kipps, Thomas J, Cymbalista, Florence, Pocock, Christopher, Thornton, Patrick, Caligaris-Cappio, Federico, Robak, Tadeusz, Delgado, Julio, Schuster, Stephen J, Montillo, Marco, Schuh, Anna, de Vos, Sven, Gill, Devinder, Bloor, Adrian, Dearden, Claire, Moreno, Carol, Jones, Jeffrey J, Chu, Alvina D, Fardis, Maria, McGreivy, Jesse, Clow, Fong, James, Danelle F, Hillmen, Peter

Volltext

Lack of the leukocyte-associated Ig-like receptor-1 expression in high-risk chronic lymphocytic leukaemia results in the absence of a negative signal regulating kinase activation a... von Poggi, A, Catellani, S, Bruzzone, A, Caligaris-Cappio, F, Gobbi, M, Zocchi, M R

Volltext

Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma von Santoro, A, Pressiani, T, Citterio, G, Rossoni, G, Donadoni, G, Pozzi, F, Rimassa, L, Personeni, N, Bozzarelli, S, Rossoni, G, Colombi, S, De Braud, F G, Caligaris-Cappio, F, Lambiase, A, Bordignon, C

Volltext

Role of the microenvironment in chronic lymphocytic leukaemia von Caligaris‐Cappio, Federico

Volltext

B-chronic lymphocytic leukemia : A malignancy of anti-self B cells von CALIGARIS-CAPPIO, F

Volltext

ZAP-70 is expressed by normal and malignant human B-cell subsets of different maturational stage von SCIELZO, C, CAMPOREALE, A, GEUNA, M, ALESSIO, M, POGGI, A, ZOCCHI, M. R, CHILOSI, M, CALIGARIS-CAPPIO, F, GHIA, P

Volltext

Growth-and Differentiation-Associated Expression of bcl-2 in B-Chronic Lymphocytic Leukemia Cells von Schena, Marina, Larsson, Lars-Gunnar, Gottardi, Daniela, Gaidano, Gianluca, Carlsson, Mats, Nilsson, Kenneth, Caligaris-Cappio, Federico

Volltext

Chronic lymphocytic leukemia: revelations from the B-cell receptor von Stevenson, Freda K., Caligaris-Cappio, Federico

Volltext

The functional in vitro response to CD40 ligation reflects a different clinical outcome in patients with chronic lymphocytic leukemia von Scielzo, C, Apollonio, B, Scarfò, L, Janus, A, Muzio, M, Ten Hacken, E, Ghia, P, Caligaris-cappio, F

Volltext

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas von FERRERI, A. J. M, DELL'ORO, S, ZAJA, F, STELITANO, C, BOBBIO, F, CORAZZELLI, G, BALDINI, L, PONZONI, M, PICOZZI, P, CAPPIO, F. Caligaris, RENI, M, FOPPOLI, M, BERNARDI, M, BRANDES, A. A, TOSONI, A, MONTANARI, M, BALZAROTTI, M, SPINA, M, ILARIUCCI, F

Volltext

An overview of chronic lymphocytic leukaemia biology von Bertilaccio, M.T.S., PhD, Scielzo, C., PhD, Muzio, M., PhD, Caligaris-Cappio, F

Volltext